Zhejiang Hisun Pharmaceutical unit passes FDA approval
Monday, June 27, 2016
Zhejiang Hisun Pharmaceutical Co., Ltd. Says its unit receives ANDA approval for its irbesartan tablets from U.S Food and Drug Administration.
Says company's unit will be able to sell its irbesartan tablets in the United States after receiving the FDA approval.
Source : reuters.com
